Back to results
US 2006/0216352 A1Published application
Rapid-acting pharmaceutical composition
AssigneeOrexo AB
InventorsChrister Nystrom, Susanne Bredenberg
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeOrexo AB
InventorsChrister Nystrom, Susanne Bredenberg
Estimating the term…
A pharmaceutical composition for the treatment of acute disorders is described. The composition includes an essentially water-free, ordered mixture of at least one pharmaceutically active agent in the form of microparticles which are adhered to the surfaces of carrier particles which are substantially larger than the particles of the active agent or agents, and are essentially insoluble or sparingly soluble in water, in combination with a bioadhesion and/or mucoadhesion promoting agent adhered to the surfaces of the carrier particles. The composition is primarily intended for sublingual or intranasal administration. The invention also relates to a method for preparing the composition and to the use of the composition for the treatment of acute disorders.
A pharmaceutical composition for the treatment of acute disorders by sublingual or intranasal administration, comprising an essentially water-free, ordered mixture of microparticles of at least one pharmaceutical active agent adhered to the surfaces of carrier particles, said particles being substantially larger than said microparticles and being insoluble or sparingly soluble in water;
18-21. (canceled)
A method for the treatment of acute disorders wherein, to an individual afflicted with said disorder, is administered sublingually or intranasally at least one dose unit of an, essentially water-free pharmaceutical composition containing an effective amount of at least one pharmaceutically active agent in the form of microparticles adhered to the surfaces of carrier particles, which are substantially larger than said microparticles and are essentially water-insoluble or sparingly water-soluble, and a bioadhesion- and/or mucoadhesion-promoting agent adhered to the surface of the carrier particles.
Dependencies are inferred from the claim text.